Talking about the COVID-19 antibody cocktail, Dr Naresh Trehan, Chairman, Medanta said that when Casirivimab and Imdevimab are injected into the infected patient in the early stage, it blocks the virus from entering the cells of the patient. The doctor termed it as a new weapon and said it is working against COVID-19 and also effective against B.1.617 variant of coronavirus.

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)